U.S. Pharmaceutical Marketing Investigations and Litigation and Indemnification Liability Risk

Risk that investigations and litigation concerning pharmaceutical marketing in the United States will result in indemnification obligations after the business transfer and future losses through escrow accounts. This includes the emergence of contingent liabilities, such as increases in estimated financial liabilities.